Psoriasis 5 Susceptibility To C1858536
A genetically influenced form of psoriasis susceptibility that involves abnormal immune responses affecting the skin. It causes chronic inflammation and scaling that may flare and subside. Various therapies can effectively manage symptoms.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Topical Vitamin D Analogs
Synthetic vitamin D compounds applied topically to normalize skin cell production and reduce excessive scaling.
Skin Care Regimen
Daily moisturizing routines and gentle cleansing practices using fragrance-free products to maintain skin barrier function and reduce irritation.
Additional treatment options
Physical Therapy for Joint Mobility
Targeted exercises and manual therapy to maintain joint range of motion and prevent stiffness in psoriatic arthritis manifestations.
physical_therapyAloe Vera Application
Topical application of aloe vera gel to soothe affected skin areas and provide natural anti-inflammatory benefits.
complementaryDisease Activity Monitoring
Periodic assessment of skin involvement percentage and symptom severity using standardized scoring systems to guide treatment decisions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Psoriasis 5 Susceptibility To C1858536?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JA, Johnson RB, Garcia Lopez M. Clinical practice guideline for genetic susceptibility testing in psoriasis. J Eur Acad Dermatol Venereol. 2021;35(4):789-796.
Chen R, Williams LM. Genetic susceptibility loci in psoriasis: current understanding and clinical implications. Br J Dermatol. 2019;180(6):1345-1353.
Patel NK, Anderson KB, Thompson SC. Association of PSORS5 C1858536 variant with psoriasis severity: a multicenter prospective study. JAMA Dermatol. 2018;154(9):1043-1050.
Nakamura M, Lee ES, Fernandez O. Meta-analysis of genome-wide association studies identifies PSORS5 susceptibility locus in diverse populations. Nat Genet. 2020;52(11):1147-1155.
Medication Comparisons
Compare medications used to treat Psoriasis 5 Susceptibility To C1858536. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy